CTCs
CityUHK, Cellomics to Develop Circulating Tumor Cell Screening Platform
Within two years, the team hopes to commercialize an assay that combines cell sorting, staining, and imaging, as well as protein and gene profiling.
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
OneCell Diagnostics Raises $16M in Series A Round
The precision oncology company plans to bring its OncoIndx Ikon liquid biopsy circulating tumor cell detection test to the US market.
USC Team Counts Circulating Tumor Cells to Predict Treatment Response, Survival in Prostate Cancer
Premium
The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.
Angle Acquires Option to License NuProbe Pan-Cancer NGS Panel
Angle said the panel would help advance its efforts to develop a liquid biopsy assay for circulating tumor cells and ctDNA.
Jun 21, 2024
Angle Raises $630K in Open Offer of Shares
Apr 24, 2024
Angle Inks Assay Development Deal with AstraZeneca
Oct 31, 2022
Aug 18, 2021
Mar 31, 2021